Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years

Abstract Mortality among end-stage renal disease patients in the United States remains unacceptably high despite progress in the management of renal replacement therapy. Consequently, there are few reports of long-term survivors on dialysis. We have analyzed characteristics of long-term (10 to 15 years, N=40) and very long-term (15 to 30 years, N=18) survivors on hemodialysis and long-term survivors (more than 10 years, N=28) on peritoneal dialysis and compared them with "average survivors" ( P